|
|
Volumn 11, Issue 13-14, 2006, Pages 573-575
|
|
A critical review of the Royal Society's report on personalized medicine
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AZATHIOPRINE;
MERCAPTOPURINE;
THIOPURINE METHYLTRANSFERASE;
TIOGUANINE;
ACUTE LYMPHOBLASTIC LEUKEMIA;
BIOTECHNOLOGY;
CANCER DIAGNOSIS;
DIAGNOSTIC PROCEDURE;
DRUG INDUSTRY;
DRUG METABOLISM;
DRUG SAFETY;
EDITORIAL;
GENETIC SCREENING;
GENETIC VARIABILITY;
HEALTH CARE QUALITY;
HEALTH CARE SYSTEM;
HEREDITY;
HUMAN;
MEDICAL DECISION MAKING;
MEDICAL PRACTICE;
PATIENT CARE;
PHARMACOGENETICS;
PHARMACOGENOMICS;
POSTMARKETING SURVEILLANCE;
UNITED STATES;
DRUG INDUSTRY;
DRUG THERAPY;
GREAT BRITAIN;
HUMANS;
PERSONAL HEALTH SERVICES;
PHARMACOGENETICS;
SOCIETIES, MEDICAL;
SOCIETIES, SCIENTIFIC;
TIME FACTORS;
UNITED STATES;
|
|
EID: 33745469009
PISSN: 13596446
EISSN: None
Source Type: Journal
DOI: 10.1016/j.drudis.2006.05.005 Document Type: Editorial |
|
Times cited : (4)
|
|
References (4)
|
